Abstract
Glucan phosphatases are a recently discovered family of enzymes that dephosphorylate either starch or glycogen and are essential for proper starch metabolism in plants and glycogen metabolism in humans. Mutations in the gene encoding the only human glucan phosphatase, laforin, result in the fatal, neurodegenerative, epilepsy known as Lafora disease. Here, we describe phosphatase assays to assess both generic laforin phosphatase activity and laforin’s unique glycogen phosphatase activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Worby CA, Gentry MS, Dixon JE (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem 281(41):30412–30418
Gentry MS, Dowen RH III, Worby CA, Mattoo S, Ecker JR, Dixon JE (2007) The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J Cell Biol 178(3):477–488
Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B, Criado-Garcia O, Fernandez-Sanchez E, Medrano-Fernandez I, Dominguez J, Garcia-Rocha M, Soriano E, Rodriguez de Cordoba S, Guinovart JJ (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10(11):1407–1413
Solaz-Fuster MC, Gimeno-Alcaniz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O, Vilchez D, Dominguez J, Garcia-Rocha M, Sanchez-Piris M, Aguado C, Knecht E, Serratosa J, Guinovart JJ, Sanz P, Rodriguez de Cordoba S (2008) Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet 17(5):667–678
Minassian BA, Ianzano L, Meloche M, Andermann E, Rouleau GA, Delgado-Escueta AV, Scherer SW (2000) Mutation spectrum and predicted function of laforin in Lafora’s progressive myoclonus epilepsy. Neurology 55(3):341–346
Wang J, Stuckey JA, Wishart MJ, Dixon JE (2002) A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J Biol Chem 277(4):2377–2380
Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev 7(11):833–846
Ganesh S, Tsurutani N, Suzuki T, Ueda K, Agarwala KL, Osada H, Delgado-Escueta AV, Yamakawa K (2003) The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain. Hum Mol Genet 12(18):2359–2368
Wang W, Roach PJ (2004) Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Biochem Biophys Res Commun 325(3):726–730
Girard JM, Le KH, Lederer F (2006) Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease. Biochimie 88(12):1961–1971
Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, Skurat AV, Delgado-Escueta AV, Minassian BA, Depaoli-Roach AA, Roach PJ (2007) Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci U S A 104(49):19262–19266
Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, Zhao X, Minassian BA, Depaoli-Roach AA, Roach PJ (2008) Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem 283(49):33816–33825
Raththagala M, Brewer MK, Parker MW, Sherwood AR, Wong BK, Hsu S, Bridges TM, Paasch BC, Hellman LM, Husodo S, Meekins DA, Taylor AO, Turner BD, Auger KD, Dukhande VV, Chakravarthy S, Sanz P, Woods VL Jr, Li S, Vander Kooi CW, Gentry MS (2015) Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. Mol Cell 57(2):261–272
Singh S, Ganesh S (2009) Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum Mutat 30(5):715–723
Gottlin EB, Xu X, Epstein DM, Burke SP, Eckstein JW, Ballou DP, Dixon JE (1996) Kinetic analysis of the catalytic domain of human cdc25B. J Biol Chem 271(44):27445–27449
Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA (1979) An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem 100(1):95–97
Harder KW, Owen P, Wong LK, Aebersold R, Clark-Lewis I, Jirik FR (1994) Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem J 298(Pt 2):395–401
McCain DF, Zhang ZY (2002) Assays for protein-tyrosine phosphatases. Methods Enzymol 345:507–518
Sherwood AR, Johnson MB, Delgado-Escueta AV, Gentry MS (2013) A bioassay for Lafora disease and laforin glucan phosphatase activity. Clin Biochem 46(18):1869–1876
Sanchez-Martin P, Raththagala M, Bridges TM, Husodo S, Gentry MS, Sanz P, Roma-Mateo C (2013) Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329. PLoS One 8(7):e69523
Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C (1997) Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272(2):843–851
Itaya K, Ui M (1966) A new micromethod for the colorimetric determination of inorganic phosphate. Clin Chim Acta 14(3):361–366
Meekins DA, Guo HF, Husodo S, Paasch BC, Bridges TM, Santelia D, Kotting O, Vander Kooi CW, Gentry MS (2013) Structure of the Arabidopsis glucan phosphatase like sex four2 reveals a unique mechanism for starch dephosphorylation. Plant Cell 25(6):2302–2314
Meekins DA, Raththagala M, Husodo S, White CJ, Guo HF, Kotting O, Vander Kooi CW, Gentry MS (2014) Phosphoglucan-bound structure of starch phosphatase Starch Excess4 reveals the mechanism for C6 specificity. Proc Natl Acad Sci U S A 111(20):7272–7277
Sherwood AR, Paasch BC, Worby CA, Gentry MS (2013) A malachite green-based assay to assess glucan phosphatase activity. Anal Biochem 435(1):54–56
Walton KM, Dixon JE (1993) Protein tyrosine phosphatases. Annu Rev Biochem 62:101–120
Dukhande VV, Rogers DM, Roma-Mateo C, Donderis J, Marina A, Taylor AO, Sanz P, Gentry MS (2011) Laforin, a dual specificity phosphatase involved in lafora disease, is present mainly as monomeric form with full phosphatase activity. PLoS One 6(8):e24040
DePaoli-Roach AA, Contreras CJ, Segvich DM, Heiss C, Ishihara M, Azadi P, Roach PJ (2015) Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease. J Biol Chem 290(2):841–850
Acknowledgments
This study was supported by grants from the Spanish Ministry of Education and Science SAF2014-54604-C3-1-R (P.S.), Generalitat Valenciana (PrometeoII/2014/029) (P.S.), NIH Grants R01NS070899 (M.S.G.), P20GM103486 (M.S.G.), Mizutani Foundation for Glycoscience Award (M.S.G.), and NSF Grant IIA-1355438 (M.S.G.). C.R.-M. was supported by the Saving Lives at Birth Consortium.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Romá-Mateo, C., Raththagala, M., Gentry, M.S., Sanz, P. (2016). Assessing the Biological Activity of the Glucan Phosphatase Laforin. In: Pulido, R. (eds) Protein Tyrosine Phosphatases. Methods in Molecular Biology, vol 1447. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3746-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3746-2_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3744-8
Online ISBN: 978-1-4939-3746-2
eBook Packages: Springer Protocols